These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24636402)

  • 1. Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.
    Jones AL; Mowry BJ; McLean DE; Mantzioris BX; Pender MP; Greer JM
    J Neuroimmunol; 2014 Apr; 269(1-2):68-75. PubMed ID: 24636402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients.
    Ganzinelli S; Borda T; Sterin-Borda L
    Neuropharmacology; 2006 Mar; 50(3):362-71. PubMed ID: 16289249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera.
    Borda T; Gomez R; Berría MI; Sterin-Borda L
    Glia; 2004 Jan; 45(2):144-54. PubMed ID: 14730708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia.
    Scarr E; Sundram S; Keriakous D; Dean B
    Biol Psychiatry; 2007 May; 61(10):1161-70. PubMed ID: 17239354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.
    Fu LX; Magnusson Y; Bergh CH; Liljeqvist JA; Waagstein F; Hjalmarson A; Hoebeke J
    J Clin Invest; 1993 May; 91(5):1964-8. PubMed ID: 7683693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part II: adult subjects.
    Spivak B; Schechtman M; Schonherz-Pine Y; Blumensohn R; Mostovoy S; Amital D; Deckmann M; Weizman A; Shinitzky M
    Neuropsychobiology; 2009; 60(1):49-54. PubMed ID: 19729973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against neonatal heart M1 muscarinic acetylcholine receptor in children with congenital heart block.
    Borda E; Sterin-Borda L
    J Autoimmun; 2001 Mar; 16(2):143-50. PubMed ID: 11247640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.
    Scarr E; Cowie TF; Kanellakis S; Sundram S; Pantelis C; Dean B
    Mol Psychiatry; 2009 Nov; 14(11):1017-23. PubMed ID: 18317461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure.
    Zhang L; Hu D; Li J; Wu Y; Liu X; Yang X
    Chin Med J (Engl); 2002 Aug; 115(8):1127-31. PubMed ID: 12215275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications.
    Reina S; Sterin-Borda L; Orman B; Borda E
    J Neuroimmunol; 2004 May; 150(1-2):107-15. PubMed ID: 15081254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor.
    Scarr E; Udawela M; Thomas EA; Dean B
    Mol Psychiatry; 2018 Feb; 23(2):295-303. PubMed ID: 27801890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors.
    du Bois TM; Newell KA; Han M; Deng C; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):37-40. PubMed ID: 18940225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
    Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
    JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
    Bacman S; Berra A; Sterin-Borda L; Borda E
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):321-7. PubMed ID: 11157861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia.
    Dean B; McLeod M; Keriakous D; McKenzie J; Scarr E
    Mol Psychiatry; 2002; 7(10):1083-91. PubMed ID: 12476323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study.
    Margari F; Petruzzelli MG; Mianulli R; Toto M; Pastore A; Bizzaro N; Tampoia M
    Psychiatry Res; 2013 Dec; 210(3):800-5. PubMed ID: 24103908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophrenia.
    Scarr E; Keriakous D; Crossland N; Dean B
    Life Sci; 2006 Feb; 78(11):1231-7. PubMed ID: 16214178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia.
    Vawter MP; Hemperly JJ; Hyde TM; Bachus SE; VanderPutten DM; Howard AL; Cannon-Spoor HE; McCoy MT; Webster MJ; Kleinman JE; Freed WJ
    Exp Neurol; 1998 Nov; 154(1):1-11. PubMed ID: 9875262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.